Young Women and Breast Cancer: The Impact of Chemotherapy on Fertility

A new study at the Dana-Farber Cancer Institute looks at the long-term effects of breast cancer chemotherapy on the ovaries of young women compared to women who have not received chemotherapy.

Knowledge of how well ovaries work following treatment is important information for young women with breast cancer. An evaluation of views about fertility for women with and without a history of breast cancer will also be conducted to better understand fertility concerns in all young women.

Enrollment is open to breast cancer survivors ages 18-42 who received chemotherapy as treatment, and continue to have menstrual periods. In addition, researchers are interested in recruiting female friends or family members who are about the age of the survivor, with no history of breast cancer, and who have never received chemotherapy. (This is not a requirement for participation.)

For more information, please contact Meghan Meyer, research coordinator, at (617) 632-4983 or mmeyer1@partners.org.